School of Medicine
Showing 401-500 of 904 Results
-
David B. Lewis
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Current Research and Scholarly InterestsMy laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.
-
Eldrin F. Lewis, MD, MPH
Simon H. Stertzer, MD, Professor
BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.
Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.
A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.
Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.
Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.
Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.
He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.
Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.
He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. -
Matthew Lewis, MD, MPH
Clinical Associate Professor, Dermatology
BioDr. Lewis specializes in autoimmune connective tissue diseases, immunobullous diseases, and other inflammatory skin diseases including psoriasis and sarcoidosis. He completed medical school at The George Washington University School of Medicine and dermatology residency at The University of Rochester, where he was chief resident. He also completed a Master’s of Public Health at Johns Hopkins and a fellowship in autoimmune connective tissue diseases at Stanford University.
He believes multidisciplinary and holistic care is key to treat patients with systemic inflammatory diseases. He holds a rheumatology-dermatology clinic with a rheumatologist, Dr. Janice Lin, as well as a dermatology-ophthalmology clinic with an ophthalmologist, Dr. Christopher Ta, and is the dermatologist for the sarcoidosis program, all with this primary goal of providing high quality, collaborative, patient-centered care. -
Richard Lewis
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
-
William Spencer Lewis, MD
Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
BioA native of the south Bay Area, Dr. Lewis brings 25 years of professional experience in the field of otolaryngology. He graduated with highest honors from UC Davis in biochemistry, and he was elected to the Alpha Omega Alpha Honor Society at the University of Southern California School of Medicine. He is Board Certified in Otolaryngology, a Qualified Medical Evaluator, a licensed Hearing Aid Dispenser, and a licensed X-Ray Supervisor/Operator. Dr. Lewis is honored to be past-president of the Santa Clara County Medical Association and past Chief of the Medical Staff at Good Samaritan Hospital.
Dr. Lewis treats both children and adults for general ear, nose and throat diseases. He has a special interest in hearing and balance problems, including chronic ear infections, sudden hearing loss, balance problems and vertigo.
When not working, Dr. Lewis has an eclectic mix of interests. He enjoys sporting events and activities, including running, swimming, cycling, golfing and basketball. He finds satisfaction in do-it-yourself home projects, especially woodworking. Above all, he loves to get out into the great outdoors and commune with nature. -
April Leyson
Section Administrative Supervisor, Surgery - General Surgery
Current Role at StanfordAdministrative Associate
For Drs. Dan E. Azagury, Byrne Lee, Carolyn Seib, and Dr. George Poultsides
Stanford Department of Surgery
Section of Bariatric and Minimally Invasive Surgery
& Section of Surgical Oncology -
Andrew A. Li, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Li is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is a clinical assistant professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine.
A therapeutic endoscopy specialist, Dr. Li received fellowship training in gastroenterology, advanced endoscopy, and endoscopic surgery at Stanford University School of Medicine. He is board certified in internal medicine and gastroenterology.
Dr. Li specializes in advanced endoscopic procedures. His areas of expertise include endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), enteroscopy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). He also specializes in esophageal peroral endoscopic myotomy (POEM), gastric peroral endoscopic myotomy (GPOEM), and Zenker’s diverticulum peroral endoscopic myotomy (ZPOEM).
In addition, he treats gastrointestinal cancers, including gastric (stomach) cancer and colon cancer. He is dedicated to helping patients by integrating leading-edge research and innovations with compassionate, patient-centered clinical care.
Dr. Li’s research interests include gastric cancer, innovations in advanced endoscopy and endoscopic surgery, and the application of artificial intelligence (AI) and other computational techniques for prevention, diagnoses, and treatments.
Dr. Li has published articles in the World Journal of Gastrointestinal Endoscopy, Gastrointestinal Endoscopy, and Endoscopy International Open. He has presented at national and international conferences held in Las Vegas; Washington, D.C.; and Seoul, Korea. In his many presentations, he has covered topics such as the prevention of gastric cancer and prevention of post-ERCP pancreatitis.
Dr. Li is a member of the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American Gastroenterological Association, and American College of Physicians. -
Caiyun Grace Li
Member, Cardiovascular Institute
Current Role at StanfordSenior Research Scientist
-
Daniel Yuhang Li
Instructor, Medicine - Cardiovascular Medicine
BioI am a physician scientist in the Division of Cardiology at Stanford. My clinical interest is at the intersection of inflammation, autoimmunity and cardiovascular disease in a field called 'Cardio-Rheumatology'. Patients with rheumatologic diseases typically have an elevated cardiovascular disease risk profile along with an insidious onset. Moreover, with the ever-expanding biologic drug formulary for patients, it is important for us to characterize the cardiovascular effects of these medications. In my research, I believe that understanding how inflammatory and autoimmune mechanisms modify coronary artery disease can help us develop a novel perspective towards treating atherosclerosis beyond lipid lowering. My research goal is to advance novel therapeutics for atherosclerosis by leveraging my expertise in genetics, computational biology, and experience with diverse model organism perturbation models. My strategy employs a ‘systems’ approach, starting with human population variations at the genetic level and integrating findings across RNA, protein, and model organism studies. This comprehensive synthesis aims to grasp the overarching biological narrative, thereby facilitating the development of translational therapies that transform concepts from bench to bedside.
-
David R. Li, MD
Affiliate, Department Funds
Fellow in Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioDr. Li is a current Critical Care Medicine fellow at Stanford Healthcare, where he stayed on after completing residency training in Emergency Medicine. He is interested in healthcare informatics and is an Epic Physician Builder. Dr. Li is active in organized medicine & health policy, currently holding leadership positions in California Medical Association, and previously serving as a California Senate legislative intern.
-
Dayan J. Li, MD, PhD
Clinical Scholar, Dermatology
Postdoctoral Scholar, Pediatric SurgeryCurrent Research and Scholarly InterestsWound healing, cutaneous fibrosis
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lingyin Li
Professor of Biochemistry
BioDr. Li is a professor in the Biochemistry Department and ChEM-H Institute at Stanford. She is also a core investigator of the Arc Institute. Her lab works on understanding biochemical mechanisms of the immunotransmitter cGAMP and harnessing it to treat cancer and autoimmunity. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology. She started her lab at Stanford in 2015.
-
Nina Li
Community Program Manager, Stanford CARE, Medicine - Med/Family and Community Medicine
Current Role at StanfordCommunity Program Manager, Stanford CARE
-
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor (Research) of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Sally S. Li
Executive Director, Medicine - Med/Family and Community Medicine
Current Role at StanfordExecutive Director, Center for Asian Health Research and Education (CARE)
-
April Shichu Liang
Affiliate, Department Funds
Fellow in Graduate Medical EducationBioApril Shichu Liang, M.D., is a fellow in the Stanford University Clinical Informatics Fellowship Program. Dr. Liang holds a B.S.E. in Computer Science from Princeton University and an M.D. from UCSF School of Medicine. She completed her Internal Medicine residency at UCSF. Dr. Liang’s clinical interests include hospital medicine, and her research interests are in implementation of machine learning tools in healthcare, clinical decision support, and data-driven quality improvement. Her past work includes the development of a machine learning model to predict incident delirium in hospitalized patients and EHR-based interventions to increase guideline-recommended public health screening.
-
David Liang, MD, PhD
Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus
BioStanford researchers are creating a micro-device that physicians could guide through the body to help diagnose and treat clogged arteries and other diseases. Tethered to the outside world by a thin wire, a tiny machine creeps through blood vessels, searching out deadly plaques and obliterating them with a zap of a laser. While a laser will come later, for now David Liang, MD, PhD, is focusing on a tiny eye that could give physicians an unprecedented view into blood vessels.
-
Charles Liao
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters
-
Congyu Liao
Instructor, Radiology
BioCongyu Liao is an Instructor in the Radiological Sciences Laboratory (RSL) at Stanford University. Dr. Liao earned his PhD in Biomedical Engineering from Zhejiang University, China, in 2018. Following his PhD, he joined the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital and Harvard Medical School as a Postdoctoral Research Fellow under Dr. Kawin Setsompop, where his research focused on improving MRI data acquisition and reconstruction efficiency. In 2021, he joined Dr. Setsompop's lab at Stanford RSL as an Instructor, with research focused on developing novel technologies for diffusion and quantitative MRI. Dr. Liao has received several honors, including the Summa Cum Laude Merit Award and the Junior Fellow Award from the International Society for Magnetic Resonance in Medicine (ISMRM). Recently, he was awarded an NIH R01 grant as Principal Investigator to use mesoscale quantitative and diffusion MRI techniques to study infant brain development.
-
Joseph Liao, MD
Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Joseph Liao, M.D., is a board-certified anesthesiologist, pain management specialist, and clinical instructor at the Stanford University School of Medicine, where he brings a wealth of expertise to the Department of Anesthesiology, Perioperative and Pain Medicine.
His clinical interests span a wide range of pain conditions with an emphasis on back pain, neck pain, joint pain, nerve pain, cancer-related pain, chronic post-surgical pain, and chronic post-traumatic pain. He specializes in neuromodulation, such as spinal cord stimulation and peripheral nerve stimulation. Dr. Liao’s expertise extends to minimally invasive surgical spine interventions, using techniques like radiofrequency ablation, percutaneous decompression, fusion, and steroid injections. He is skilled in using ultrasonography and fluoroscopy to address spine, degenerative joint, and musculoskeletal diseases, as well as neurolysis and ablation for cancer-related pain.
In his research, Dr. Liao focuses on innovative therapies through neuromodulation and minimally invasive spine interventions, with his work published in prestigious peer-reviewed journals such as Anesthesiology and Pain Medicine. He serves as an ad hoc reviewer for multiple pain and anesthesiology journals. He is actively engaged in presenting and teaching at national and international conferences.
Dr. Liao is an avid patient and physician advocate. He takes pride in facilitating safe care and enjoys teaching other physicians how to safely deliver anesthetics and pain care in various forums. He adheres to the philosophy of applying the right treatment for the right patient at the right time. His goal is to utilize minimally invasive interventions to enhance functionality, elevate quality of life, and alleviate pain.
He serves on leadership boards and is affiliated with numerous esteemed medical associations such as the American Society of Interventional Pain Physicians, American Society of Pain and Neuroscience, North American Neuromodulation Society, International Association for the Study of Pain, American Academy of Pain Medicine, Pacific Spine and Pain Society, California Society of Interventional Pain Physicians, American Society of Anesthesiologists, American Association for the Surgery of Trauma, Society of Critical Care Medicine, and World Academy of Pain Medicine United. -
Joseph C. Liao
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally. -
Y. Joyce Liao, MD, PhD
Stanford Medicine Professor of Ophthalmology and Professor of Neurology and Neurological Sciences
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Yungting Liao
Clinical Associate Professor, Pediatrics
Current Research and Scholarly Interestsclinical informatics, quality improvement
-
Cara A. Liebert, MD, FACS
Clinical Assistant Professor, Surgery - General Surgery
Current Research and Scholarly InterestsCurrent research interests include Surgical Education and Minimally Invasive Surgery. Primary research focus is the development, implementation, and collection of validity evidence for ENTRUST, an online virtual patient simulation platform for assessment of clinical decision-making.
